Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q1 2022
Institutional positions in Calidi Biotherapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +13 vs. Q4 2021
- Shares held
- 20.5M
- +3.69M (+22.0%) vs. Q4 2021
- Total value
- $202.4M
- +$37.7M (+22.9%) vs. Q4 2021
- New holders
- 13
- 9 more added
- Sold out
- 0
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $656.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.56M |
| Q4 2023 | 25 | $3.29M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $40.6M |
| Q1 2023 | 27 | $45.8M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $214.8M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $184.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 1,980,000 | $19.6M | 0.24% | 00.0% | Unchanged |
| Woodline Partners LP | 1,980,000 | $19.6M | 0.33% | 00.0% | Unchanged |
| Apollo Management Holdings, L.P. | 1,935,454 | $19.1M | 0.12% | −44,546−2.2% | Reduced |
| Driehaus Capital Management LLC | 1,500,000 | $14.8M | 0.18% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 1,200,000 | $11.9M | 0.70% | +1,000,000+500.0% | Added |
| Shaolin Capital Management LLC | 1,170,675 | $11.6M | 0.29% | +995,675+569.0% | Added |
| Beryl Capital Management LLC | 1,159,998 | $11.5M | 0.69% | 00.0% | Unchanged |
| Marshall Wace, LLP | 1,062,226 | $10.5M | 0.02% | 00.0% | Unchanged |
| Governors Lane LP | 1,000,000 | $9.89M | 0.76% | 00.0% | Unchanged |
| Aristeia Capital LLC | 990,000 | $9.79M | 0.18% | +990,000 | New |
| D. E. Shaw & Co., Inc. | 819,775 | $8.11M | 0.01% | +3,959+0.5% | Added |
| Periscope Capital Inc. | 727,216 | $7.19M | 0.19% | +51,316+7.6% | Added |
| Saba Capital Management, L.P. | 621,500 | $6.15M | 0.10% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 559,179 | $5.53M | 0.14% | −1,024,290−64.7% | Reduced |
| Sculptor Capital LP | 500,000 | $4.95M | 0.04% | 00.0% | Unchanged |
| Millennium Management LLC | 494,801 | $4.89M | 0.01% | +494,801 | New |
| Radcliffe Capital Management, L.P. | 400,480 | $3.96M | 0.10% | +480+0.1% | Added |
| Wolverine Asset Management LLC | 326,503 | $3.23M | 0.04% | +139,598+74.7% | Added |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 300,000 | $2.97M | 0.03% | 00.0% | Unchanged |
| Berkley W R Corp | 235,621 | $2.33M | 0.12% | 00.0% | Unchanged |
| Nomura Holdings Inc | 185,636 | $1.83M | 0.01% | +185,636 | New |
| Rpo LLC | 174,392 | $1.72M | 0.59% | +174,392 | New |
| Centiva Capital, LP | 174,020 | $1.72M | 0.10% | +174,020 | New |
| Blackstone Group Inc. | 170,842 | $1.69M | 0.00% | +170,842 | New |
| Goldman Sachs Group Inc | 127,076 | $1.26M | 0.00% | +37,109+41.2% | Added |
| Deutsche Bank AG | 100,000 | $989.0K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 100,000 | $987.0K | 0.00% | +100,000 | New |
| Boothbay Fund Management, LLC | 87,198 | $862.0K | 0.03% | +87,198 | New |
| Prelude Capital Management, LLC | 60,100 | $594.0K | 0.03% | +60,100 | New |
| Pinz Capital Management, LP | 57,000 | $564.0K | 0.35% | 00.0% | Unchanged |
| Linden Advisors LP | 50,000 | $495.0K | 0.00% | 00.0% | Unchanged |
| Segantii Capital Management Ltd | 50,000 | $495.0K | 0.02% | 00.0% | Unchanged |
| CNH Partners LLC | 40,584 | $401.0K | 0.01% | −1,408−3.4% | Reduced |
| Kohlberg Kravis Roberts & Co. L.P. | 35,317 | $349.0K | 0.00% | +8,794+33.2% | Added |
| Arena Investors LP | 35,123 | $347.0K | 0.23% | +35,123 | New |
| Schonfeld Strategic Advisors LLC | 27,320 | $270.0K | 0.00% | +27,320 | New |
| Old Mission Capital LLC | 26,775 | $265.0K | 0.01% | +26,775 | New |
| Cohanzick Management, LLC | 2,550 | $25.0K | 0.01% | +2,550 | New |
| Dark Forest Capital Management LP | 2,000 | $19.0K | 0.00% | +643+47.4% | Added |
| UBS Group AG | 1,547 | $15.0K | 0.00% | −5,868−79.1% | Reduced |